Keightley Amen

Articles by Keightley Amen

Keightley AmenConferences | December 28, 2022
Research has shown that weight gain and obesity can be associated with an increased risk of developing breast cancer.
Read More
Keightley AmenConferences | December 28, 2022
Some research has shown that patients with certain autoimmune diseases have a lower risk of breast cancer.
Keightley AmenConferences | December 28, 2022
“CTCs contribute to the metastatic cascade and represent an independent survival predictor in breast cancer."
Keightley AmenConferences | December 28, 2022
Research has shown that women with breast cancer who live in socioeconomically disadvantaged areas have poorer outcomes.
Keightley AmenConferences | December 28, 2022
Breast cancer that is hormone receptor (HR)-positive tends to be diagnosed early, when it is highly treatable.
Keightley AmenConferences | December 28, 2022
The new research was presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.
Keightley AmenConferences | December 28, 2022
Younger patients with breast cancer tend to have a poorer prognosis and higher rates of recurrence.
Keightley AmenConferences | December 28, 2022
Many low-income areas of the world still experience poor outcomes and lack information to guide improvements.
Keightley AmenConferences | December 28, 2022
A study examined the effectiveness of adding pyrotinib, a new tyrosine kinase inhibitor (TKI).
Keightley AmenConferences | December 28, 2022
Identification of human epidermal growth factor receptor 2 status is important in breast cancer diagnosis.
Keightley AmenConferences | December 28, 2022
Much research has examined the effects of body mass index (BMI) on breast cancer risk and outcomes.
Keightley AmenConferences | December 28, 2022
Triple-negative breast cancer tends to have relatively poor long-term outcomes compared to other subtypes of breast cancer.
Keightley AmenConferences | December 28, 2022
According to data presented at ASCO 2022, Afib is associated with worse outcomes from breast cancer.
Keightley AmenConferences | December 28, 2022
In developed countries, breast cancer treatment has become much more effective due to advances in molecular subtyping.
Keightley AmenConferences | December 28, 2022
A study presented at ASCO 2022 provided data on a new method using MRI and 3D printing to create breast surgical guides.
Keightley AmenConferences | December 28, 2022
Biomarker assessment is a very useful tool often used to make treatment decisions.
Keightley AmenConferences | December 28, 2022
The authors described their experiences with prepectoral implant placement.
Keightley AmenConferences | December 28, 2022
A retrospective review identified female patients with HER2-positive breast cancer who started therapy with TDM1 or TDXd.
Keightley AmenConferences | December 28, 2022
The new data is being used to develop a biomarker tool to predict the efficacy of neoadjuvant pembrolizumab.
Keightley AmenConferences | December 28, 2022
Many studies are examining COVID-19's impact on particular subgroups of patients with cancer.